A multimodality score strategy for assessing the risk of immune checkpoint inhibitors related cardiotoxicity.

MLA

Chen, Zhulu, et al. “A Multimodality Score Strategy for Assessing the Risk of Immune Checkpoint Inhibitors Related Cardiotoxicity.” Scientific Reports, vol. 14, no. 1, Oct. 2024, p. 24821. EBSCOhost, https://doi.org/10.1038/s41598-024-76829-5.

APA

Chen, Z., Lan, R., Ran, T., Tao, L., Zhu, Y., Li, Y., Zhang, C., Mao, M., Gao, D., & Zuo, Z. (2024). A multimodality score strategy for assessing the risk of immune checkpoint inhibitors related cardiotoxicity. Scientific Reports, 14(1), 24821. https://doi.org/10.1038/s41598-024-76829-5

Chicago

Chen, Zhulu, Rui Lan, Tao Ran, Li Tao, Yuxi Zhu, Yanwei Li, Chuan Zhang, Min Mao, Diansa Gao, and Zhong Zuo. 2024. “A Multimodality Score Strategy for Assessing the Risk of Immune Checkpoint Inhibitors Related Cardiotoxicity.” Scientific Reports 14 (1): 24821. doi:10.1038/s41598-024-76829-5.